The development of noninvasive methods to detect and monitor tumors continues to be a bottleneck in oncology research. Circulating cell-free DNA shows great promise, but still requires improvements and additional research before it becomes standard practice. At Cambridge Healthtech Institute’s ...
Read More »NanoString’s Hyb & Seq™ Enables Liquid Biopsy by the Direct Capture and Sequencing of Cell-Free DNA
NanoString Technologies, Inc, a provider of life science tools for translational research and molecular diagnostic products, today announced that the company has demonstrated the capability of its Hyb & Seq technology to perform liquid biopsy measurement. The proof-of-principle work was ...
Read More »New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes
Cell-free DNA (cfDNA) in blood is used as a source of genetic material for noninvasive prenatal and cancer diagnostic assays in clinical practice. While characterizing exosomes found in human blood plasma, University of Nebraska Medical Center researchers observed the presence of ...
Read More »Caution Advised in Leaping on the Liquid Biopsy Bandwagon
from OncLive by Meir Rinde – The booming field of research on blood tests for cancer has drawn billions in venture capital funding and raised the hopes of doctors and patients for a new era of detection and treatment. A ...
Read More »UW Study Demonstrates Tracking of Cell-Free DNA to Origin in Body
NEW YORK (GenomeWeb) – In a new study published in Cell today, researchers have shown for the first time that by analyzing deeply sequenced cell-free DNA and the spacing of nucleosomes, it is possible to determine the bodily origin of ...
Read More »Upcoming Conference – Second Annual – Circulating Cell-Free DNA
Part of Molecular Diagnostics Europe – 4-7 April, 2016, Sheraton Lisboa, Lisbon, Portugal Circulating tumour DNA has grown in popularity given its ability to detect minimal residual disease and monitor treatment. Regardless of growing proof of its utility, much needs ...
Read More »Circulating Cell-Free DNA Conference – 2016
Cambridge Healthtech Institute’s Third Annual Circulating Cell-Free DNA Clinical Directions and Emerging Avenues for Early Detection March 10-11, 2016 | Hilton San Francisco Union Square | San Francisco, CA Part of the 23rd International Molecular Medicine Tri-Conference Preliminary Agenda | ...
Read More »Upcoming Webinar – Circulating cell-free DNA (cfDNA) as liquid biopsy
A 4-part webinar series Part 3: Liquid biopsy: overcome challenges of cfDNA with automated and standardized extraction processes July 21, 9:30am EDT In this webinar, we present data on solutions for the following critical problems concerning the purification of cfDNA ...
Read More »